Press Releases

Cannanda CB2 Dog-Ease is Back in Stock: The World's #1 Beta-Caryophyllene Supplement for Dogs Returns

TORONTO, ON, April 14, 2025 /3DMC Press/ -- After being out of stock for over a month due to overwhelming demand, Cannanda is thrilled to announce that CB2 Dog-Ease Hemp Seed Oil is finally back in stock...

Cannanda launches direct sales in the UK of their trademarked CB2 products with guaranteed authentic beta-caryophyllene CB2 oils.

The World’s Top-Selling Beta-Caryophyllene Products Now Available in the UK

London, United Kingdom, March 4, 2025 /3DMC Press/ – Cannanda, the global leader in beta-caryophyllene health solutions and creator of CB2 oils, is proud to announce the launch of its direct-to-consumer (DTC) sales in the United Kingdom.

Cannanda, the creator of CB2 oils, world's best-selling beta-caryophyllene (BCP) products, Australian direct-to-consumer market, guaranteed authentic

Cannanda CB2 Oils: The World’s Top-Selling Beta-Caryophyllene Supplements Now Available in Australia

Cannanda, the global leader and original creator of CB2 oils, is proud to announce the launch of its direct-to-consumer (DTC) sales in Australia. Known for producing the world’s best-selling and highest-quality beta-caryophyllene (BCP) products, Cannanda’s entry into the Australian market...

Cannanda CB2 oils take the title for the world's best-selling beta-caryophyllene products.

Cannanda CB2 Oils Declared World’s Best-Selling Beta-Caryophyllene (BCP) Supplements

Cannanda, the trusted name in natural health innovation, is proud to announce that Cannanda CB2 Oil has achieved the self-affirmed title of the world's top-selling beta-caryophyllene (BCP) products.

Cannanda's Money-Back Guarantee on Its Award-Winning Beta-Caryophyllene Supplements (aka CB2 Oils)

Cannanda, a leader in the natural health industry, proudly reaffirms its commitment to customer satisfaction with its no-hassle money-back guarantee for its award-winning beta-caryophyllene (BCP) supplements--CB2 oils.

Premium CB2 oils in Australia, Canada, United Kingdom, and Unites States. Whether it's for pain, sleep, or anxiety, the best BCP product for you depends on a variety of factors and Cannanda helps make it easy to choose; and provides education on how to av

Premium CB2 Oils: Selecting the Best Beta-Caryophyllene Supplement for You

Toronto, ON, August 30, 2024 /3DMC Press/ – Cannanda, the pioneer that created the category of terpenes as a natural health solution, is pleased to announce new guidance to help customers select the most suitable "CB2 Oil" product from its diverse lineup. These products, based on beta-caryophyllene (BCP), are gaining...

As many consumers have come to realize the therapeutic potential of beta-caryophyllene, many ask, “what’s the difference between Cannanda CB2 oil and plain isolated beta-caryophyllene?”

Buying Beta-Caryophyllene Isolates Vs. CB2 Oil

TORONTO, ON, July 17, 2024 /3DMC Press/ – With the growing demand for beta-caryophyllene (BCP) products in the natural health and wellness sector, Cannanda, the pioneering inventor of CB2 oil, emphasizes the importance of discerning between CB2 oil and BCP isolates to make informed buying decisions.

Sesh Intention, available as a room spray or a pure aromatherapy concentrate, is a new innovation from Cannanda and meant to be used as a tool to help manifest optimal health outcomes.

SESH Intention & Manifestation Spray: A Revolution in Well-being

Toronto, ON, May 20, 2024 /3DMC Press/ – Cannanda, the pioneering company known for its outside-the-box innovations in the wellness industry—including its renowned CB2 oils—proudly announces the launch of SESH® Intention Room Spray, a groundbreaking fragrance designed to work with the power of positive intention to help manifest optimal health outcomes.

CB2 Oils: Real CB2 oils vs Fake CB2 copycats in Australia

Cannanda Issues Warning Against Counterfeit CB2 Oils: Protect Yourself from Fraudulent Beta-Caryophyllene Products

TORONTO, ON, April 24, 2024 /3DMC Press/ – Cannanda, the pioneering inventor of CB2 oil, issues a critical warning to consumers amidst the proliferation of counterfeit CB2 oils flooding the market. With the exponential growth in demand for natural health alternatives, the rise of fraudulent products poses significant risks to consumers' health and well-being.

Cannanda CB2 oil best non-marine vegan omega-3 high in SDA

Cannanda Repositions CB2 Hemp Seed Oil as Sustainable and Versatile Vegan Omega 3-6-9 Product

HALIFAX, NS, January 31, 2024 /3DMC Press/ – Cannanda, the innovative company behind the award-winning CB2 oil, is excited to announce the repositioning of their CB2 Hemp Seed Oil as a versatile Omega 3-6-9 product, and available exclusively through Amazon.ca. This move comes as a response to the growing demand for sustainable alternatives to fish oils, and Cannanda is proud to offer a solution that not only benefits the environment but also provides numerous health benefits.

Cannanda launches free trial program for beta-caryophyllene CB2 oil for patients with ME/CFS, long covid, and fibromyalgia

Cannanda Launches Free Trial Program for CB2 Oil, Offering Hope to ME/CFS, Long Covid, and Fibromyalgia Patients

Cannanda CB2 products, featuring beta-caryophyllene, are already being used in the Remission Biome clinical trial for ME/CFS and long covid

TORONTO, ON, January 15, 2024 /3DMC Press/ – Cannanda, the trailblazing innovator behind CB2 oil, proudly announces the launch of a Free Trial program, offering individuals with ME/CFS, long covid, and fibromyalgia a risk-free opportunity...

Cannanda CB2 oil has been selected to be a part of the largest patient-led self-experiment protocol ever run for ME/CFS & long COVID

Remission Biome Chooses Cannanda CB2 Oil for Groundbreaking Experimental Protocol in the Battle Against ME/CFS and Long COVID

VANCOUVER, BC, November 2, 2023 /3DMC Press/ — Cannanda, a pioneer in botanical terpene solutions, is excited to announce a significant milestone in the ongoing quest to bring relief to individuals suffering from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Long COVID, and related conditions like fibromyalgia.